IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
17 hedge funds and large institutions have $3.55M invested in Interpace Biosciences, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$91K | |
| 2 | +$43K | |
| 3 | +$13K | |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$11.8K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$3.84K |
Top Sellers
| 1 | -$108K | |
| 2 | -$40K | |
| 3 | -$32.3K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.75K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$5K |